|
|
||||||||
The Journal of Immunology, Vol 146, Issue 2 449-456, Copyright © 1991 by American Association of Immunologists
ARTICLES |
MT Michalek, B Benacerraf and KL Rock
Department of Pathology, Harvard Medical School, Boston, MA 02115.
This report describes the effects of NH4Cl, CH3NH2, and chloroquine on class I and II MHC-restricted Ag presentation. OVA-specific T-T hybridomas were used to detect processed OVA in association with class I, H-2Kb, and class II, I-Ad/b, molecules on a B lymphoblastoid APC. OVA, internalized by APC under hypertonic conditions, was presented in association with class I and II MHC molecules. Treating the APC with NH4Cl or CH3NH2 inhibited class I- and II-restricted Ag presentation. In contrast, chloroquine markedly inhibited class II, but not class I- restricted Ag presentation. Controls indicated that drug-treated APC were fully competent to interact with T cells and present processing- independent antigenic peptides in association with both class I and II MHC molecules. NH4Cl and CH3NH2 did not inhibit the uptake of radiolabeled Ag by the APC. After the proteolytic removal of H-2Kb from the surface of APC, NH4Cl and CH3NH2-treated and control APC regenerated identical amounts of surface H-2Kb and this regeneration required de novo protein synthesis. These latter results indicate that NH4Cl and CH3NH2 can inhibit Ag presentation without affecting the synthesis, transport, or surface expression of H-2Kb. Also, NH4Cl did not affect the transport of H-2Db to the surface of mutant RMA-S cells that were cultured with exogenous peptides. Taken together these results strongly suggest that NH4Cl and CH3NH2 but not chloroquine can inhibit a critical and early intracellular step in class I-restricted Ag presentation while simultaneously inhibiting class II-restricted Ag presentation.
This article has been cited by other articles:
![]() |
P. Bansal, P. Mukherjee, S. K. Basu, A. George, V. Bal, and S. Rath MHC Class I-Restricted Presentation of Maleylated Protein Binding to Scavenger Receptors J. Immunol., April 15, 1999; 162(8): 4430 - 4437. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |